Benitec Biopharma Limited Company Profile (NASDAQ:BNTC)

About Benitec Biopharma Limited

Benitec Biopharma Limited logoBenitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic. It is focused on commercialization by licensing and partnering of patents and licenses in biotechnology, in functional genomics, with applications in biomedical research and human therapeutics. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid (DNA)-directed ribonucleic acid interference (ddRNAi). The Company is engaged in developing treatments for chronic human conditions, such as hepatitis B, wet age-related macular degeneration (AMD), and oculopharyngeal muscular dystrophy (OPMD) based on this technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BNTC
  • CUSIP:
Key Metrics:
  • Previous Close: $2.47
  • 50 Day Moving Average: $2.3495
  • 200 Day Moving Average: $1.7484
  • 52-Week Range: $1.20 - $4.44
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -10.96
  • P/E Growth: 0.0000
  • Market Cap: $19.65M
  • Outstanding Shares: 7,326,000
  • Beta: 2.53
Debt:
  • Current Ratio: 21.89%
  • Quick Ratio: 21.89%
Additional Links:
Companies Related to Benitec Biopharma Limited:

Analyst Ratings

Consensus Ratings for Benitec Biopharma Limited (NASDAQ:BNTC) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Benitec Biopharma Limited (NASDAQ:BNTC)
Show:
DateFirmActionRatingPrice TargetDetails
2/3/2017Maxim GroupReiterated RatingHoldView Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Benitec Biopharma Limited (NASDAQ:BNTC)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Benitec Biopharma Limited (NASDAQ:BNTC)
Current Year EPS Consensus Estimate: $-0.10 EPS
Next Year EPS Consensus Estimate: $-0.24 EPS

Dividends

Dividend History for Benitec Biopharma Limited (NASDAQ:BNTC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Benitec Biopharma Limited (NASDAQ:BNTC)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Benitec Biopharma Limited (NASDAQ:BNTC)
DateHeadline
News IconAfter rocky road, Aussie firm Benitec gets new life via Nantworks deal (NASDAQ:BNTC)
www.bioworld.com - February 18 at 3:51 PM
4-traders.com logoBenitec Biopharma : HBV DATA PRESENTATION AT APASL SHANGHAI (NASDAQ:BNTC)
www.4-traders.com - February 16 at 9:04 PM
News IconBenitec Biopharma Ltd. (BNTC) — Shares in Focus (NASDAQ:BNTC)
xboxonezone.com - February 16 at 4:03 PM
finance.yahoo.com logoBenitec Biopharma to present expanded data set from pivotal data in hepatitis B virus (HBV) in vivo model at International Liver Meeting in Shanghai, China (NASDAQ:BNTC)
finance.yahoo.com - February 16 at 8:49 AM
News IconBenitec Biopharma Limited (NASDAQ:BNTC) shows optimistic Trends (NASDAQ:BNTC)
mundoaguaysaneamiento.net - February 5 at 8:58 PM
investing.com logoU.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.94% (NASDAQ:BNTC)
www.investing.com - February 3 at 9:09 PM
finance.yahoo.com logoM&A Activity Could Kick Start Biotech Industry's Recovery in 2017: Today's Report on Benitec and Protalix (NASDAQ:BNTC)
finance.yahoo.com - February 3 at 4:09 PM
benzinga.com logoMid-Day Market Update: Shutterfly Drops On Downbeat Earnings; Mead Johnson Shares Spike Higher (NASDAQ:BNTC)
www.benzinga.com - February 2 at 9:14 PM
investing.com logoU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.06% (NASDAQ:BNTC)
www.investing.com - February 2 at 4:09 PM
nasdaq.com logoMid-Afternoon Market Update: Weatherford Rises Following Q4 Results; Ralph Lauren Shares Plunge (NASDAQ:BNTC)
www.nasdaq.com - February 2 at 4:09 PM
finance.yahoo.com logoBenitec Biopharma makes significant progress in ocular program (NASDAQ:BNTC)
finance.yahoo.com - February 2 at 4:09 PM
streetinsider.com logoBenitec Biopharma (BNTC) Gains After Announces Progress on ddRNAi Technology (NASDAQ:BNTC)
www.streetinsider.com - February 2 at 4:09 PM
schaeffersresearch.com logoEdwards Lifesciences, Benitec Biopharma, Stemline Therapeutics Stocks Moving Today (NASDAQ:BNTC)
www.schaeffersresearch.com - February 2 at 4:09 PM
finance.yahoo.com logoWhy Benitec More Than Doubled (NASDAQ:BNTC)
finance.yahoo.com - February 2 at 4:09 PM
investingnews.com logoBenitec Biopharma Executes Research Collaboration with Nant Capital (NASDAQ:BNTC)
investingnews.com - January 30 at 8:53 PM
finance.yahoo.com logoBenitec initiates development work on head and neck cancer programs after executing Collaboration Agreement with Nant Capital (NASDAQ:BNTC)
finance.yahoo.com - January 30 at 3:52 PM
4-traders.com logoBenitec Biopharma : ONCOLOGY PROGRAM INITIATED WITH NANT (NASDAQ:BNTC)
www.4-traders.com - January 29 at 8:58 PM
fxpips.com logoComposite Trading Summary: Top 20 Decliners (NASDAQ:BNTC)
www.fxpips.com - January 25 at 2:35 AM
fxpips.com logoCOMPOSITE Trading: Top Decliners – SSH, ZYNE, RCII, GNC, DFFN, APRI, IZEA, BVXV, SPHS, ITUS, DVCR, AVGR, CHCI, WKHS, FNCX, AAN, SBBP, BNTC (NASDAQ:BNTC)
www.fxpips.com - January 20 at 3:10 AM
247wallst.com logoTuesday’s Top Biopharma Movers (NASDAQ:BNTC)
247wallst.com - January 19 at 5:03 PM
rttnews.com logoBenitec Biopharma (BNTC) Leaped After European Orphan Drug Designation (NASDAQ:BNTC)
www.rttnews.com - January 19 at 5:03 PM
nasdaq.com logoBUZZ-U.S. STOCKS ON THE MOVE-Goldman Sachs, Target, CoLucid, Apricus Biosciences (NASDAQ:BNTC)
m.nasdaq.com - January 18 at 3:24 PM
benzinga.com logoBenitec Receives Orphan Drug Designation in the... (NASDAQ:BNTC)
www.benzinga.com - January 18 at 3:24 PM
4-traders.com logoBenitec Biopharma : ANNOUNCES EU ODD FOR BB301 (NASDAQ:BNTC)
www.4-traders.com - January 18 at 3:24 PM
streetinsider.com logoBenitec Biopharma (BNTC) BB-301 Granted Orphan Drug Designation in EU (NASDAQ:BNTC)
www.streetinsider.com - January 18 at 3:24 PM
finance.yahoo.com logoBlog Coverage Benitec Biopharma Secures Orphan Drug Designation for its Product Treating Patients with Oculopharyngeal Muscular Dystrophy (NASDAQ:BNTC)
finance.yahoo.com - January 18 at 3:24 PM
finance.yahoo.com logoBenitec Stock Up on Orphan Drug Status for BB-301 in EU (NASDAQ:BNTC)
finance.yahoo.com - January 18 at 3:24 PM
finance.yahoo.com logoBiotech Industry Outperforming Markets in 2017: Latest Reports on Benitec Biopharma and Tandem Diabetes Care (NASDAQ:BNTC)
finance.yahoo.com - January 18 at 3:24 PM
us.rd.yahoo.com logoBenitec Receives Orphan Drug Designation in the European Union for BB-301, a ddRNAi Therapeutic in Development for the Treatment of Oculopharyngeal Muscular Dystrophy (NASDAQ:BNTC)
us.rd.yahoo.com - January 17 at 9:32 AM
publicnow.com logoBENITEC TO PRESENT AT BIOTECH SHOWCASE (NASDAQ:BNTC)
www.publicnow.com - January 5 at 9:56 PM
us.rd.yahoo.com logoBenitec in-licenses clinical program for head and neck cancer from NantWorks (NASDAQ:BNTC)
us.rd.yahoo.com - December 23 at 4:07 PM
us.rd.yahoo.com logo7:13 am Benitec Biopharma in-licenses clinical program for head and neck cancer from NantWorks; financial terms not disclosed (NASDAQ:BNTC)
us.rd.yahoo.com - December 23 at 4:07 PM
publicnow.com logoCancer program in-licensed from Nant (NASDAQ:BNTC)
www.publicnow.com - December 22 at 9:04 PM
finance.yahoo.com logoBenitec releases pivotal data in an in vivo hepatitis B model (NASDAQ:BNTC)
finance.yahoo.com - December 20 at 8:00 AM
finance.yahoo.com logo7:38 am Benitec Biopharma announced significant progress on use of the company's technology for development of a ddRNAi based therapeutic for the treatment of hepatitis B virus (NASDAQ:BNTC)
finance.yahoo.com - December 20 at 8:00 AM
4-traders.com logoBenitec Biopharma : AGM PROXY VOTES (NASDAQ:BNTC)
www.4-traders.com - December 14 at 2:39 AM
publicnow.com logoINTERIM REPORT THREE MONTHS TO 30 SEPTEMBER 2016 (NASDAQ:BNTC)
www.publicnow.com - November 22 at 11:43 AM
publicnow.com logoQUARTERLY CORPORATE UPDATE CALL (NASDAQ:BNTC)
www.publicnow.com - November 17 at 8:57 PM
publicnow.com logoStrateigc engagement with NantVentures (NASDAQ:BNTC)
www.publicnow.com - October 24 at 8:53 AM
publicnow.com logoBenitec announces date of AGM (NASDAQ:BNTC)
www.publicnow.com - October 24 at 8:53 AM
publicnow.com logoAppendix 3B Nant Capital Placement (NASDAQ:BNTC)
www.publicnow.com - October 24 at 8:53 AM
publicnow.com logoCleansing Notice Re Nant Capital (NASDAQ:BNTC)
www.publicnow.com - October 24 at 8:53 AM
4-traders.com logoBenitec Biopharma : PRESENTS AT ESGCT (NASDAQ:BNTC)
www.4-traders.com - October 20 at 3:25 PM
publicnow.com logoBENITEC PRESENTS AT ESGCT (NASDAQ:BNTC)
www.publicnow.com - October 20 at 9:48 AM
publicnow.com logoCHANGE IN REGISTERED OFFICE (NASDAQ:BNTC)
www.publicnow.com - October 20 at 9:48 AM
4-traders.com logoBenitec Biopharma : CHANGE IN COMPANY SECRETARY (NASDAQ:BNTC)
www.4-traders.com - October 18 at 3:52 PM
publicnow.com logoResponse to ASX Appendix 3X and 3Y Query (NASDAQ:BNTC)
www.publicnow.com - October 13 at 10:56 AM
capitalcube.com logoBenitec Biopharma Ltd. :BNTC-US: Earnings Analysis: 2016 By the Numbers : September 23, 2016 (NASDAQ:BNTC)
www.capitalcube.com - September 23 at 3:22 PM
News IconNasdaq Index Boosted by Yellen at Crucial Turning Point, Reaches New Record High (NASDAQ:BNTC)
www.economiccalendar.com - September 22 at 8:08 AM
4-traders.com logoBenitec Biopharma : ANNOUNCES TT-034 CLINICAL STUDY RESULTS (NASDAQ:BNTC)
www.4-traders.com - September 15 at 8:53 PM

Social

What is Benitec Biopharma Limited's stock symbol?

Benitec Biopharma Limited trades on the NASDAQ under the ticker symbol "BNTC."

Where is Benitec Biopharma Limited's stock going? Where will Benitec Biopharma Limited's stock price be in 2017?

1 equities research analysts have issued twelve-month price objectives for Benitec Biopharma Limited's stock. Their predictions range from $10,000,000.00 to $0.00. On average, they expect Benitec Biopharma Limited's share price to reach $0.00 in the next twelve months.

How do I buy Benitec Biopharma Limited stock?

Shares of Benitec Biopharma Limited can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Benitec Biopharma Limited stock cost?

One share of Benitec Biopharma Limited stock can currently be purchased for approximately $2.63.

Benitec Biopharma Limited (NASDAQ:BNTC) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Benitec Biopharma Limited (NASDAQ:BNTC)

Earnings History Chart

Earnings by Quarter for Benitec Biopharma Limited (NASDAQ:BNTC)

Dividend History Chart

Dividend Payments by Quarter for Benitec Biopharma Limited (NASDAQ:BNTC)

Last Updated on 2/27/2017 by MarketBeat.com Staff